Our Story
Over the Years
MAY 2023
GeneSys Bio Ltd. is born
- Andrea, Enrico, Simone and Luciano found GeneSys Bio with the goal of bringing their innovation to market
JULY 2023
Next Age
- The GeneSys project completes the Next Age acceleration path created on the initiative of CDP Venture Capital and AC75 Startup Accelerator, obtaining the first investment
SEPTEMBER 2023
POC development
- The Proof-Of-Concept of the device is realized.
SEPTEMBER 2023
EIT Health Bridgehead Europe – Siemens Healthineers
- The GeneSys project is selected within EIT Health’s Bridghead Europe program and is selected by Siemens Healthineers for the matchmaking phase
OCTOBER 2023
Meet In Italy For Life Sciences 2023
- GeneSys Bio is selected to present its project at MIT4LS, one of Italy’s premier events for life sciences startups
OCTOBER 2023
Fundable
- GeneSys Bio wins first Fundable event dedicated to startups in product development stage
MARCH 2024
BBS Startup Ecosystem Day + Hackaton
- GeneSys Bio is selected by the prestigious Bologna Business School to participate in Startup Ecosystem Day and be the subject of a Business Hackathon
MARCH 2024
First patent filing
- GeneSys Bio files patent application for kit dedicated to Urinary Tract Infections
APRIL 2024
Maverx Innovation Bootcamp
- GeneSys Bio partecipa al MaverX Innovation Bootcamp e Pitch presentation ed entra in contatto con interessanti attori della Biomedical Valley
MAY 2024
Boost Your Ideas by Lazio Innova
- GeneSys Bio, selected from more than 200 startups, wins first prize in Boost Your Ideas program organized by Lazio Region and Lazio Innova
JUNE 2024
WMF | We Make Future
- GeneSys Bio is selected to present its project during the World Startup Fest, part of the We Make Future 24
JUNE 2024
Pre-Seed Plus by Lazio Innova
- GeneSys Bio wins the maximum grant made available by Lazio Innova through the Pre-Seed Plus call for proposals
JULY 2024
EIT Health Open Innovation Programme
- GeneSys Bio is selected among the most innovative approaches in Europe for diagnosing Sexually Transmitted Diseases and participates in EIT Health Open Innovation Programme’s STI Challenge.
SEPTEMBER 2024
Plug and Play – Showcase
- GeneSys Bio selected to present in front of more than 100 VC investors with a combined AUM of more than $10 billion
SEPTEMBER 2024
The Rome Startup Week 2024
- GeneSys Bio selected from over 120 applicants to participate in the Startup Program during Rome Startup Week 2024
